Sudden itchy scalp and shedding after 2 years of treatment
    Treatment 6/18/2023

    From the encyclopedia
    Finasteride →

    Frontline, gold standard treatment for combatting androgenic alopecia

    Minoxidil →

    An essential vasodilator with some anti-androgenic effects

    RU58841 →

    a potent but unapproved and potentially problematic topical anti-androgen

    At a glance
    In this side effect report post, the primary subjects mentioned are
    💊 Finasteride (oral) 1x daily 2 years
    💧 Minoxidil (topical) 2 years
    💧 RU58841 (topical) 100mg
    💊 Dutasteride (oral) 1x weekly
    the tone is 😞 negative with good results.

    Other terms

    After 2 years of using finasteride and minoxidil with good results, the user is experiencing severe scalp itchiness, shedding, and tenderness. Despite dermatologists finding nothing wrong, the user seeks over-the-counter treatments for the itch.
    View this post in the Community →

    Similar Community Posts Join

    5 / 5 results

      community Anyone ever get a shedding phase on RU58441

      in Chat  6 upvotes 1 year ago
      The user experienced increased hair shedding after using RU58841 for two months, but found relief from scalp itchiness. Other users shared similar shedding experiences and discussed side effects like joint pain, while also mentioning the use of finasteride and minoxidil.

      community September - december with fin + oral & topical min + ru58841.

       165 upvotes 1 year ago
      The user experienced hair regrowth using finasteride, oral and topical minoxidil, and RU58841, despite initial shedding. They also transitioned from finasteride to dutasteride and addressed scalp issues with a folliculitis shampoo.

      community I’m on a crazy hairloss stack and I’m still losing hair and not experiencing any regrowth. What is going on?

       31 upvotes 2 years ago
      The user is using a combination of hair loss treatments including finasteride, stemoxydine, oral minoxidil, RU58841, dermastamping, ketoconazole shampoo, collagen, Viviscal, and biotin, and has improved their diet. Despite these efforts, they are still experiencing hair shedding and scalp itchiness, and are considering increasing their minoxidil dosage or starting dutasteride.

      community What is everyone's assessment of pyrilutamide 1.0% topical as a adjunct treatment?

       5 upvotes 3 months ago
      The conversation discusses the use of pyrilutamide as an adjunct treatment for hair loss, particularly for those already using finasteride and minoxidil. Users share mixed experiences, with some reporting side effects like numbness and gynecomastia, while others note its potential benefits in reducing shedding and scalp itchiness.

    Related Research

    6 / 6 results
      Overactive Bladder in Men: Finasteride for Androgenetic Alopecia

      research Overactive bladder in men

      1 citations , January 2009 in “CRC Press eBooks”
      This chapter discusses the increasing prevalence of overactive bladder in aging men, examining potential causes and treatment options, without reporting new clinical results.
      Phytochemicals as Emerging Therapeutic Agents for Alopecia Treatment

      research Phytochemicals as emerging therapeutic agents for alopecia treatment

      January 2020 in “Elsevier eBooks”
      This chapter provides an overview of phytochemicals with properties to combat alopecia and discusses the potential of flavonoids, found in several herbs, as a safer alternative to synthetic hair loss treatments due to their long-term skin compatibility.
      Hair Loss in Women

      research Hair Loss in Women

      January 2012 in “Postgraduate obstetrics & gynecology”
      Up to 50% of women may experience significant hair loss by age 50, with various causes and treatments available.
      Hair Loss in Women

      research Hair Loss in Women

      January 2012 in “Postgraduate obstetrics & gynecology”
      This descriptive abstract provides information about a continuing medical education activity for physicians, designating 1.5 credits for participation, but reports no new research findings.